Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Is proton therapy the silver bullet for children with brain cancer?
Adelaide is poised to open Australia’s first proton therapy centre in 2025, with children and…
Is proton therapy the silver bullet for children with brain cancer?
Adelaide is poised to open Australia’s first proton therapy centre in 2025, with children and…
Tomosynthesis with synthetic mammography improves breast cancer detection
Digital breast tomosynthesis (DBT), in combination with synthetic mammography, improves cancer detection over digital mammography…
Hormonal contraceptives and hair dyes increase breast cancer risk
In her recent doctoral dissertation, researcher Sanna Heikkinen from the University of Helsinki and Finnish Cancer Registry evaluates the contribution…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.